• Cristiana Sessa, Dominik T Schneider, François Planchamp, Katja Baust, Elena Ioana Braicu, Nicole Concin, Jan Godzinski, W Glenn McCluggage, Daniel Orbach, Patricia Pautier, Fedro A Peccatori, Philippe Morice, and Gabriele Calaminus.
• Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. Electronic address: cristiana.sessa@eoc.ch.
• Lancet Oncol. 2020 Jul 1; 21 (7): e360-e368.

AbstractThe European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma of the ovary of hypercalcaemic type. The developmental process of these guidelines is based on a systematic literature review and critical appraisal process involving an international multidisciplinary developmental group consisting of experts from relevant disciplines (paediatric oncology, paediatric surgery, medical oncology, pathology, psycho-oncology, gynaecological oncology, and reproductive endocrinology). Given the specific and often complex issues involved in treating this group of patients, fertility sparing surgery and decrease of acute and long-term toxicities from treatment were important criteria for guidelines definition. Prior to publication, the guidelines were reviewed by 54 independent international practitioners in cancer care delivery.Copyright © 2020 Elsevier Ltd. All rights reserved.

15 keywords...

hide…